Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis

OncoImmunology

Volumn 4, Issue 12, 2015, Pages

  Däster, Silvio ^a,b   Eppenberger Castori, Serenella ^c   Hirt, Christian ^a,b   Soysal, Savas D ^a,b   Delko, Tarik ^a   Nebiker, Christian A ^a,b   Weixler, Benjamin ^a   Amicarella, Francesca ^b   Iezzi, Giandomenica ^b   Governa, Valeria ^b   Padovan, Elisabetta ^b   Mele, Valentina ^b   Sconocchia, Giuseppe ^d   Heberer, Michael ^b   Terracciano, Luigi ^c   Kettelhack, Christoph ^a   Oertli, Daniel ^a   Spagnoli, Giulio C ^b   von Holzen, Urs ^a,e   Tornillo, Luigi ^c   Droeser, Raoul A ^a,b   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD8+; human colorectal cancer; myeloperoxidase; prognostic markers; tissue microarray

Indexed keywords

GRANZYME B; MYELOPEROXIDASE;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL DENSITY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PROTEIN EXPRESSION; SURVIVAL RATE; TISSUE MICROARRAY;

EID: 84944517995     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1050574     Document Type: Article

References (40)

1. J.Ferlay, I.Soerjomataram, M.Ervik, R.Dikshit, S.Eser, C.Mathers, M.Rebelo, D.M.Parkin, D.Forman, F.Bray. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. Eleven; Available from: http://globocan.iarc.fr/
2. L.D.Wood, D.W.Parsons, S.Jones, J.Lin, T.Sjöblom, R.J.Leary, D.Shen, S.M.Boca, T.Barber, J.Ptak et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108-13; PMID:17932254; http://dx.doi.org/10.1126/science.1145720
3. S.Ogino, A.T.Chan, C.S.Fuchs, E.Giovannucci. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011; 60:397-411; PMID:21036793; http://dx.doi.org/10.1136/gut.2010.217182
4. A.Walther, R.Houlston, I.Tomlinson. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008; 57:941-50; PMID:18364437; http://dx.doi.org/10.1136/gut.2007.135004
5. S.Popat, R.Hubner, R.S.Houlston. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23:609-18; PMID:15659508
6. L.M.Coussens, Z.Werb. Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322
7. D.Hanahan, R.A.Weinberg. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
8. J.Galon, A.Costes, F.Sanchez-Cabo, A.Kirilovsky, B.Mlecnik, C.Lagorce-Pagès, M.Tosolini, M.Camus, A.Berger, P.Wind et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
9. B.Mlecnik, M.Tosolini, P.Charoentong, A.Kirilovsky, G.Bindea, A.Berger, M.Camus, M.Gillard, P.Bruneval, W.-H.Fridman et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 2010; 138:1429-40; PMID:19909745; http://dx.doi.org/10.1053/j.gastro.2009.10.057
10. F.Pagès, A.Berger, M.Camus, F.Sanchez-Cabo, A.Costes, R.Molidor, B.Mlecnik, A.Kirilovsky, M.Nilsson, D.Damotte et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; PMID:16371631
11. M.Tosolini, A.Kirilovsky, B.Mlecnik, T.Fredriksen, S.Mauger, G.Bindea, A.Berger, P.Bruneval, W.-H.Fridman, F.Pagès et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976
12. W.H.Fridman, F.Pagès, C.Sautès-Fridman, J.Galon. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253
13. F.Grizzi, P.Bianchi, A.Malesci, L.Laghi. Prognostic value of innate and adaptive immunity in colorectal cancer. World J Gastroenterol 2013; 19:174-84; PMID:23345940
14. B.Mlecnik, M.Tosolini, A.Kirilovsky, A.Berger, G.Bindea, T.Meatchi, P.Bruneval, Z.Trajanoski, W.-H.Fridman, F.Pagès et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 2011; 29:610-8; PMID:21245428
15. F.Prall, T.Dührkop, V.Weirich, C.Ostwald, P.Lenz, H.Nizze, M.Barten. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 2004; 35:808-16; PMID:15257543
16. I.Zlobec, E.Karamitopoulou, L.Terracciano, S.Piscuoglio, G.Iezzi, M.G.Muraro, G.Spagnoli, K.Baker, A.Tzankov, A.Lugli. TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer. PLoS One 2010; 5:e14282; PMID:21179245; http://dx.doi.org/10.1371/journal.pone.0014282
17. S.Coca, J.Perez-Piqueras, D.Martinez, A.Colmenarejo, M.A.Saez, C.Vallejo, J.A.Martos, M.Moreno. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997; 79:2320-8; PMID:9191519; http://dx.doi.org/10.1002/(SICI)1097-0142(19970615)79:12%3c2320::AID-CNCR5%3e3.0.CO;2-P
18. N.Halama, M.Braun, C.Kahlert, A.Spille, C.Quack, N.Rahbari, M.Koch, J.Weitz, M.Kloor, I.Zoernig et al. Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res 2011; 17:678-89; PMID:21325295
19. G.Sconocchia, R.Arriga, L.Tornillo, L.Terracciano, S.Ferrone, G.C.Spagnoli. Melanoma cells inhibit NK cell functions. Cancer Res 2012; 72:5428-9; PMID:23047870
20. J.Forssell, A.Oberg, M.L.Henriksson, R.Stenling, A.Jung, R.Palmqvist. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13:1472-9; PMID:17332291
21. D.Nagorsen, S.Voigt, E.Berg, H.Stein, E.Thiel, C.Loddenkemper. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 2007; 5:62; PMID:18047662
22. M.Pancione, N.Forte, L.Sabatino, E.Tomaselli, D.Parente, A.Febbraro, V.Colantuoni. Reduced β-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome. Hum Pathol 2009; 40:714-25; PMID:19121846
23. G.Sconocchia, I.Zlobec, A.Lugli, D.Calabrese, G.Iezzi, E.Karamitopoulou, E.S.Patsouris, G.Peros, M.Horcic, L.Tornillo et al. Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011; 128:2663-72; PMID:20715106
24. R.A.Droeser, C.Hirt, S.Eppenberger-Castori, I.Zlobec, C.T.Viehl, D.M.Frey, C.A.Nebiker, R.Rosso, M.Zuber, F.Amicarella et al. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One 2013; 8:e64814; PMID:23734221; http://dx.doi.org/10.1371/journal.pone.0064814
25. E.Di Carlo, G.Forni, P.Lollini, M.P.Colombo, A.Modesti, P.Musiani. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001; 97:339-45; PMID:11154206
26. A.Stoppacciaro, C.Melani, M.Parenza, A.Mastracchio, C.Bassi, C.Baroni, G.Parmiani, M.P.Colombo. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J Exp Med 1993; 178:151-61; PMID:7686211
27. M.P.Colombo, G.Ferrari, A.Stoppacciaro, M.Parenza, M.Rodolfo, F.Mavilio, G.Parmiani. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 1991; 173:889-97; PMID:1706752
28. E.B.Eruslanov, P.S.Bhojnagarwala, J.G.Quatromoni, T.L.Stephen, A.Ranganathan, C.Deshpande, T.Akimova, A.Vachani, L.Litzky, W.W.Hancock et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 2014; 124:5466-80; PMID:25384214
29. J.R.Jass, W.S.Atkin, J.Cuzick, H.J.Bussey, B.C.Morson, J.M.Northover, I.P.Todd. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986; 10:437-59; PMID:3721406; http://dx.doi.org/10.1111/j.1365-2559.1986.tb02497.x
30. D.M.Frey, R.A.Droeser, C.T.Viehl, I.Zlobec, A.Lugli, U.Zingg, D.Oertli, C.Kettelhack, L.Terracciano, L.Tornillo. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 2010; 126:2635-43; PMID:19856313
31. I.Zlobec, A.Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010; 1:651-61; PMID:21317460
32. Z.G.Fridlender, S.M.Albelda. Tumor-associated neutrophils: friend or foe? Carcinogenesis 2012; 33:949-55; PMID:22425643; http://dx.doi.org/10.1093/carcin/bgs123
33. Z.G.Fridlender, J.Sun, S.Kim, V.Kapoor, G.Cheng, L.Ling, G.S.Worthen, S.M.Albelda. Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell 2009; 16:183-94; PMID:19732719; http://dx.doi.org/10.1016/j.ccr.2009.06.017
34. C.A.Nebiker, J.Han, S.Eppenberger-Castori, G.Iezzi, C.Hirt, F.Amicarella, E.Cremonesi, X.Huber, E.Padovan, B.Angrisani et al. GM-CSF Production by tumor cells Is associated with improved survival in colorectal cancer. Clin Cancer Res 2014; 20:3094-106; PMID:24737547; http://dx.doi.org/10.1158/1078-0432.CCR-13-2774
35. R.G.Urdinguio, A.F.Fernandez, A.Moncada-Pazos, C.Huidobro, R.M.Rodriguez, C.Ferrero, P.Martinez-Camblor, A.J.Obaya, T.Bernal, A.Parra-Blanco et al. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors. Cancer Res 2013; 73:395-405; PMID:23108143; http://dx.doi.org/10.1158/0008-5472.CAN-12-0806
36. H.L.Rao, J.W.Chen, M.Li, Y.B.Xiao, J.Fu, Y.X.Zeng, M.Y.Cai, D.Xie. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS One 2012; 7:e30806; PMID:22295111; http://dx.doi.org/10.1371/journal.pone.0030806
37. S.Trellakis, K.Bruderek, C.A.Dumitru, H.Gholaman, X.Gu, A.Bankfalvi, A.Scherag, J.Hütte, N.Dominas, G.F.Lehnerdt et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 2011; 129:2183-93; PMID:21190185; http://dx.doi.org/10.1002/ijc.25892
38. T.Yatsunenko, F.E.Rey, M.J.Manary, I.Trehan, M.G.Dominguez-Bello, M.Contreras, M.Magris, G.Hidalgo, R.N.Baldassano, A.P.Anokhin et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-7; PMID:22699611
39. S.Viaud, R.Daillère, I.G.Boneca, P.Lepage, P.Langella, M.Chamaillard, M.J.Pittet, F.Ghiringhelli, G.Trinchieri, R.Goldszmid et al. Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ 2015; 22:199-214; PMID:24832470; http://dx.doi.org/10.1038/cdd.2014.56
40. S.Turcotte, S.C.Katz, J.Shia, W.R.Jamagin, T.P.Kingham, P.J.Allen, Y.Fong, M.I.D'Angelica, R.P.DeMatteo. Tumor MHC Class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. Cancer Immunol Res 2014; 2:530-7; PMID:24894090; http://dx.doi.org/10.1158/2326-6066.CIR-13-0180